TEX29
gene geneOn this page
Also known as bA474D23.1MGC35169
Summary
TEX29 (testis expressed 29, HGNC:20370) is a protein-coding gene on chromosome 13q34, encoding Testis-expressed protein 29 (Q8N6K0).
Predicted to be located in membrane.
Source: NCBI Gene 121793 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 37 total — 1 likely-pathogenic
- MANE Select transcript:
NM_152324
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20370 |
| Approved symbol | TEX29 |
| Name | testis expressed 29 |
| Location | 13q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA474D23.1, MGC35169 |
| Ensembl gene | ENSG00000153495 |
| Ensembl biotype | protein_coding |
| Entrez | 121793 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000283547, ENST00000497241, ENST00000904792
RefSeq mRNA: 2 — MANE Select: NM_152324
NM_001303133, NM_152324
CCDS: CCDS9522
Canonical transcript exons
ENST00000283547 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001011089 | 111328183 | 111328293 |
| ENSE00001235276 | 111320642 | 111320762 |
| ENSE00001235286 | 111344083 | 111344248 |
| ENSE00003500585 | 111320857 | 111320948 |
| ENSE00003503466 | 111342756 | 111342931 |
| ENSE00003655964 | 111339863 | 111339932 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 92.78.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0542 / max 41.9509, expressed in 5 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 136117 | 0.0348 | 3 |
| 207109 | 0.0116 | 2 |
| 136116 | 0.0078 | 3 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 92.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.74 | gold quality |
| right testis | UBERON:0004534 | 91.90 | gold quality |
| testis | UBERON:0000473 | 89.52 | gold quality |
| sperm | CL:0000019 | 86.90 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.36 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.12 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.79 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 78.95 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.70 | silver quality |
| prefrontal cortex | UBERON:0000451 | 77.40 | gold quality |
| frontal cortex | UBERON:0001870 | 75.63 | gold quality |
| neocortex | UBERON:0001950 | 74.99 | gold quality |
| cerebral cortex | UBERON:0000956 | 72.42 | gold quality |
| amygdala | UBERON:0001876 | 72.13 | gold quality |
| primary visual cortex | UBERON:0002436 | 70.85 | gold quality |
| caudate nucleus | UBERON:0001873 | 70.72 | gold quality |
| putamen | UBERON:0001874 | 70.00 | gold quality |
| popliteal artery | UBERON:0002250 | 69.68 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 69.66 | silver quality |
| tibial artery | UBERON:0007610 | 69.65 | gold quality |
| left coronary artery | UBERON:0001626 | 69.17 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 69.16 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 69.13 | gold quality |
| forebrain | UBERON:0001890 | 68.84 | gold quality |
| aorta | UBERON:0000947 | 67.91 | gold quality |
| coronary artery | UBERON:0001621 | 67.37 | gold quality |
| brain | UBERON:0000955 | 67.02 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.85 | gold quality |
| nucleus accumbens | UBERON:0001882 | 66.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting TEX29, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-6804-3P | 98.72 | 64.82 | 852 |
| HSA-MIR-1261 | 98.62 | 68.10 | 896 |
| HSA-MIR-4718 | 98.55 | 68.61 | 814 |
| HSA-MIR-6884-3P | 98.05 | 65.32 | 750 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tex29 | ENSMUSG00000031512 |
| rattus_norvegicus | Tex29 | ENSRNOG00000033585 |
Protein
Protein identifiers
Testis-expressed protein 29 — Q8N6K0 (reviewed: Q8N6K0)
All UniProt accessions (2): Q8N6K0, F2Z350
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (2): NP_001290062, NP_689537* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031685 | TEX29 | Family |
Pfam: PF15839
UniProt features (6 total): topological domain 2, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6K0-F1 | 59.56 | 0.14 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
CHANG_IMMORTALIZED_BY_HPV31_DN, chr13q34, NFKBIA_TARGET_GENES, MIR6884_3P, BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP, BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP, NOTCH3_TARGET_GENES, GSE27786_LIN_NEG_VS_CD4_TCELL_UP, GSE27786_LIN_NEG_VS_CD8_TCELL_UP, GSE27786_LIN_NEG_VS_NKTCELL_UP, GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP, GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP, GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP, GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN, GSE24210_TCONV_VS_TREG_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
306 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX29 | CCDC112 | Q8NEF3 | 669 |
| TEX29 | TEX30 | Q5JUR7 | 605 |
| TEX29 | C21orf140 | B9A014 | 570 |
| TEX29 | DPH7 | Q9BTV6 | 519 |
| TEX29 | FAM9C | Q8IZT9 | 484 |
| TEX29 | RAD51AP2 | Q09MP3 | 479 |
| TEX29 | TEX13C | A0A0J9YWL9 | 449 |
| TEX29 | C1orf53 | Q5VUE5 | 432 |
| TEX29 | TEX12 | Q9BXU0 | 422 |
| TEX29 | IQCF3 | P0C7M6 | 419 |
| TEX29 | HIGD1C | A8MV81 | 414 |
| TEX29 | WDR70 | Q9NW82 | 404 |
| TEX29 | ACRV1 | P26436 | 390 |
| TEX29 | TEX13A | Q9BXU3 | 368 |
| TEX29 | TEX22 | C9J3V5 | 367 |
IntAct
73 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| APOD | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFPL1 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DERL3 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM3C | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RUSF1 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM140 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CMTM7 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCO4 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAL | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMBIM6 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM190 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRAC | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB2 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLEC7A | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPHB5 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM147 | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM86B | TEX29 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (67): NDFIP1 (Affinity Capture-MS), FLVCR1 (Affinity Capture-MS), HIP1R (Affinity Capture-MS), TOR1A (Affinity Capture-MS), LEMD3 (Affinity Capture-MS), SLC4A7 (Affinity Capture-MS), FAM207A (Affinity Capture-MS), PLAA (Affinity Capture-MS), SLC6A15 (Affinity Capture-MS), PTS (Affinity Capture-MS), STEAP3 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), SLC16A2 (Affinity Capture-MS), ZDHHC9 (Affinity Capture-MS), STX10 (Affinity Capture-MS)
ESM2 similar proteins: A1DWM3, A9ZLX4, F1N4M2, F1QFU0, F6QZ15, O54828, O73698, O75151, O75916, P17863, P49140, P49805, Q04679, Q08B84, Q13191, Q28C33, Q3SZT4, Q3TTA7, Q3UN70, Q4KUS2, Q5F3L9, Q5RH73, Q5U3K5, Q5ZKN3, Q62739, Q62768, Q68FR2, Q6DFR2, Q6GQL0, Q6NRE7, Q7T0Z7, Q7TPJ0, Q86XR5, Q8CB19, Q8K467, Q8K4S7, Q8N3S3, Q8N6K0, Q8NEW7, Q8TDI7
Diamond homologs: Q3SZT4, Q6AXY3, Q8N6K0, Q9DA77
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 25 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 148303 | GRCh38/hg38 13q34(chr13:111118651-114340331)x3 | Likely pathogenic |
SpliceAI
1086 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:111320945:ACAGG:A | donor_loss | 1.0000 |
| 13:111320948:GGTA:G | donor_loss | 1.0000 |
| 13:111320949:G:GA | donor_loss | 1.0000 |
| 13:111320949:G:GG | donor_gain | 1.0000 |
| 13:111320950:T:G | donor_loss | 1.0000 |
| 13:111328181:A:AG | acceptor_gain | 1.0000 |
| 13:111328182:G:GT | acceptor_gain | 1.0000 |
| 13:111328182:GT:G | acceptor_gain | 1.0000 |
| 13:111328182:GTGT:G | acceptor_gain | 1.0000 |
| 13:111328294:G:GG | donor_gain | 1.0000 |
| 13:111342754:A:AG | acceptor_gain | 1.0000 |
| 13:111342755:G:GG | acceptor_gain | 1.0000 |
| 13:111342755:GA:G | acceptor_gain | 1.0000 |
| 13:111342755:GAGTC:G | acceptor_gain | 1.0000 |
| 13:111320762:GGT:G | donor_loss | 0.9900 |
| 13:111320763:G:GC | donor_loss | 0.9900 |
| 13:111320764:T:G | donor_loss | 0.9900 |
| 13:111320958:G:T | donor_gain | 0.9900 |
| 13:111328177:TTGCA:T | acceptor_loss | 0.9900 |
| 13:111328178:TGCA:T | acceptor_loss | 0.9900 |
| 13:111328179:GCAGT:G | acceptor_loss | 0.9900 |
| 13:111328180:CAGTG:C | acceptor_loss | 0.9900 |
| 13:111328181:AGT:A | acceptor_gain | 0.9900 |
| 13:111328181:AGTGT:A | acceptor_gain | 0.9900 |
| 13:111328182:GTG:G | acceptor_gain | 0.9900 |
| 13:111328182:GTGTG:G | acceptor_gain | 0.9900 |
| 13:111339827:T:TA | acceptor_gain | 0.9900 |
| 13:111342752:TCA:T | acceptor_loss | 0.9900 |
| 13:111342752:TCAG:T | acceptor_gain | 0.9900 |
| 13:111342753:CAG:C | acceptor_gain | 0.9900 |
AlphaMissense
990 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:111328236:T:A | C38S | 0.949 |
| 13:111328237:G:C | C38S | 0.949 |
| 13:111328257:T:C | F45L | 0.949 |
| 13:111328259:C:A | F45L | 0.949 |
| 13:111328259:C:G | F45L | 0.949 |
| 13:111328272:T:A | C50S | 0.945 |
| 13:111328273:G:C | C50S | 0.945 |
| 13:111328272:T:C | C50R | 0.925 |
| 13:111339902:C:A | A70D | 0.921 |
| 13:111328236:T:C | C38R | 0.920 |
| 13:111339877:T:C | F62L | 0.918 |
| 13:111339879:C:A | F62L | 0.918 |
| 13:111339879:C:G | F62L | 0.918 |
| 13:111328274:C:G | C50W | 0.917 |
| 13:111339904:G:A | G71R | 0.911 |
| 13:111339904:G:C | G71R | 0.911 |
| 13:111328273:G:A | C50Y | 0.910 |
| 13:111320942:T:C | F18L | 0.909 |
| 13:111320944:C:A | F18L | 0.909 |
| 13:111320944:C:G | F18L | 0.909 |
| 13:111339914:T:A | V74D | 0.909 |
| 13:111328209:T:A | C29S | 0.906 |
| 13:111328210:G:C | C29S | 0.906 |
| 13:111328238:C:G | C38W | 0.897 |
| 13:111328210:G:A | C29Y | 0.895 |
| 13:111339905:G:A | G71E | 0.885 |
| 13:111328251:T:A | C43S | 0.883 |
| 13:111328252:G:C | C43S | 0.883 |
| 13:111328258:T:G | F45C | 0.883 |
| 13:111328237:G:A | C38Y | 0.880 |
dbSNP variants (sampled 300 via entrez): RS1000099377 (13:111335292 A>C), RS1000159211 (13:111331746 G>A), RS1000280741 (13:111326727 C>A,T), RS1000316190 (13:111332759 G>GT), RS1000348881 (13:111332447 A>AT), RS1000441913 (13:111322197 T>C), RS1000460527 (13:111338463 C>A,G), RS1000472781 (13:111337570 C>T), RS1000649798 (13:111327907 G>A), RS1000665147 (13:111322973 C>T), RS1000687424 (13:111333860 C>T), RS1000777900 (13:111323191 G>A,T), RS1000831200 (13:111338713 T>C), RS1000877257 (13:111318512 C>A,T), RS1000950680 (13:111318319 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000880_2 | Menarche (age at onset) | 6.000000e-08 |
| GCST002541_96 | Menarche (age at onset) | 2.000000e-17 |
| GCST002935_27 | Lead levels | 9.000000e-06 |
| GCST003993_3 | Menarche (age at onset) | 1.000000e-08 |
| GCST004750_38 | Squamous cell lung carcinoma | 5.000000e-06 |
| GCST005023_19 | Initial pursuit acceleration | 7.000000e-06 |
| GCST007576_68 | Chronotype | 4.000000e-09 |
| GCST008803_8 | Smoking behaviour (cigarette pack-years) | 8.000000e-10 |
| GCST010988_477 | Adult body size | 2.000000e-11 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004703 | age at menarche |
| EFO:0008434 | initial pursuit acceleration |
| EFO:0008328 | chronotype measurement |
| EFO:0009115 | tobacco smoke exposure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| mono-(2-ethylhexyl)phthalate | increases abundance, increases methylation | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Diethylhexyl Phthalate | increases abundance, increases methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.